Silvio Aprile
Novara, 28100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Discovery of a Dual IDO1/TDO Inhibitor That Modulates Enzymatic Activity and IDO1/SHP-2 Signaling.
Journal: Journal of medicinal chemistry
Published: July 22, 2026
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy.
Journal: Journal of medicinal chemistry
Published: February 19, 2026
Exploring the pharmaceutical potential of ammonium organotrifluoroborate functional group: Comprehensive chemical, metabolic, and plasma stability evaluation.
Journal: European journal of medicinal chemistry
Published: July 02, 2024
The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators.
Journal: European journal of medicinal chemistry
Published: May 06, 2024
Spray-Dried Powder Containing Cannabigerol: A New Extemporaneous Emulgel for Topical Administration.
Spray-Dried Powder Containing Cannabigerol: A New Extemporaneous Emulgel for Topical Administration.
Journal: Pharmaceutics
Published: November 08, 2023
Correction to "An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline".
Journal: ACS medicinal chemistry letters
Published: October 31, 2023
Selective inhibition of indoleamine and tryptophan 2,3-dioxygenases: Comparative study on kynurenine pathway in cell lines via LC-MS/MS-based targeted metabolomics.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 29, 2023
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.
Journal: International journal of molecular sciences
Published: March 16, 2023
Quantification of the Chemical Chaperone 4-Phenylbutyric Acid (4-PBA) in Cell Culture Media via LC-HRMS: Applications in Fields of Neurodegeneration and Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 23, 2022
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs.
Journal: Journal of medicinal chemistry
Published: November 02, 2022
Last Updated: 09/26/2026